• By ICR Secretariat
  • Posted Thursday, July 14, 2022

10 clinical trials to watch in the second half of 2022

https://www.biopharmadive.com/news/biotech-10-clinical-trials-watch-2022-second-half/625359/

Highly anticipated study readouts in cancer, Alzheimer’s disease and schizophrenia could determine whether the biotech industry’s slump continues.